» Articles » PMID: 35858406

Tropism of SARS-CoV-2 for Human Cortical Astrocytes

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) readily infects a variety of cell types impacting the function of vital organ systems, with particularly severe impact on respiratory function. Neurological symptoms, which range in severity, accompany as many as one-third of COVID-19 cases, indicating a potential vulnerability of neural cell types. To assess whether human cortical cells can be directly infected by SARS-CoV-2, we utilized stem-cell-derived cortical organoids as well as primary human cortical tissue, both from developmental and adult stages. We find significant and predominant infection in cortical astrocytes in both primary tissue and organoid cultures, with minimal infection of other cortical populations. Infected and bystander astrocytes have a corresponding increase in inflammatory gene expression, reactivity characteristics, increased cytokine and growth factor signaling, and cellular stress. Although human cortical cells, particularly astrocytes, have no observable ACE2 expression, we find high levels of coronavirus coreceptors in infected astrocytes, including CD147 and DPP4. Decreasing coreceptor abundance and activity reduces overall infection rate, and increasing expression is sufficient to promote infection. Thus, we find tropism of SARS-CoV-2 for human astrocytes resulting in inflammatory gliosis-type injury that is dependent on coronavirus coreceptors.

Citing Articles

A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.

Rubio A, Hamilton L, Bausch M, Jin M, Papetti A, Jiang P J Neuroimmune Pharmacol. 2025; 20(1):23.

PMID: 39987404 PMC: 11846768. DOI: 10.1007/s11481-025-10181-x.


iPSC-derived human cortical organoids display profound alterations of cellular homeostasis following SARS-CoV-2 infection and Spike protein exposure.

Cappelletti G, Brambilla L, Strizzi S, Limanaqi F, Melzi V, Rizzuti M FASEB J. 2025; 39(4):e70396.

PMID: 39950320 PMC: 11826378. DOI: 10.1096/fj.202401604RRR.


SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?.

Luo E, Chang R, Gilbert-Jaramillo J Brain Behav Immun Health. 2025; 42:100888.

PMID: 39881814 PMC: 11776083. DOI: 10.1016/j.bbih.2024.100888.


SARS-CoV-2 Is an Electricity-Driven Virus.

McCaig C Rev Physiol Biochem Pharmacol. 2025; 187():361-410.

PMID: 39838019 DOI: 10.1007/978-3-031-68827-0_18.


Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.

Skarne N, DSouza R, Palethorpe H, Bradbrook K, Gomez G, Day B Acta Neuropathol Commun. 2025; 13(1):6.

PMID: 39799339 PMC: 11724554. DOI: 10.1186/s40478-025-01928-x.


References
1.
Garcia-Flores V, Romero R, Xu Y, Theis K, Arenas-Hernandez M, Miller D . Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun. 2022; 13(1):320. PMC: 8766450. DOI: 10.1038/s41467-021-27745-z. View

2.
Taquet M, Geddes J, Husain M, Luciano S, Harrison P . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5):416-427. PMC: 8023694. DOI: 10.1016/S2215-0366(21)00084-5. View

3.
Jin R, Xiao A, Chen R, Granger D, Li G . Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation. Stroke. 2017; 48(12):3356-3365. PMC: 5726599. DOI: 10.1161/STROKEAHA.117.018839. View

4.
Singh M, Bansal V, Feschotte C . A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. Cell Rep. 2020; 32(12):108175. PMC: 7470764. DOI: 10.1016/j.celrep.2020.108175. View

5.
Leng K, Rose I, Kim H, Xia W, Romero-Fernandez W, Rooney B . CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states. Nat Neurosci. 2022; 25(11):1528-1542. PMC: 9633461. DOI: 10.1038/s41593-022-01180-9. View